I suspect EYE will have better revenue growth when they release their latest figures considering they had 65% growth even when 2 months were negatively affected by uncertainty about insurance reimbursement (which have now been resolved) and they've recently increased their sales force.
But yes agreed 75% growth is impressive. Looks like Vanguard have picked a winner
Ann: First $A9M sales month and $A10M revenue month, page-19
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.35 |
Change
0.020(0.86%) |
Mkt cap ! $1.623B | |||
| Open | High | Low | Value | Volume |
| $2.27 | $2.37 | $2.27 | $3.035M | 1.301M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 26580 | $2.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.37 | 12054 | 2 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |